Overview
Nexstim is a Finnish medical technology company specializing in navigated brain stimulation, offering the NBS System for neurosurgical planning and the NBT System for treating major depressive disorder with TMS. Their proprietary eXimia technology provides precise, image-guided transcranial magnetic stimulation.
More in Neuromodulation
Latest industry news
BlueWind Medical's Revi Extend Wins FDA Clearance, Extending Implant Life to 15 Years
2026-08-06 · Product
Neurofeedback Systems Market Eyes $2.95 Billion Valuation by 2035 as Clinical and Consumer Demand Converge
2026-08-05 · Industry
Smaller Neuromodulation Devices Are Reshaping the Competitive Landscape for TMS Providers
2026-08-04 · Industry
NIH-Backed Brain-Computer Device Restores Speech in Paralyzed Patient
2026-08-03 · Research
Company details
Category
⚡ Neuromodulation
Location
Helsinki, Finland
Funding
Public · Helsinki Stock Exchange
Website
www.nexstim.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →